Summary
Inflammatory biomarkers in ischemic acute coronary syndrome
Domínguez-Rodríguez A, Abreu-González P
Affiliation of the authors
Servicio de Cardiología, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Tenerife, España. Facultad de Ciencias de la Salud, Universidad Europea de Canarias, La Orotava, Tenerife, España. Departamento de Ciencias Médicas Básicas, Unidad de Fisiología, Universidad de La Laguna, Tenerife, España.
DOI
Quote
Domínguez-Rodríguez A, Abreu-González P. Inflammatory biomarkers in ischemic acute coronary syndrome. Emergencias. 2015;27:319-24
Summary
Diagnosing acute coronary syndrome (ACS) in the emergency department is often a complex process. Inflammatory markers might be useful for the rapid assessment of a patient’s overall risk and might also help predict future episodes. The clinical use of these biomarkers could potentially lower the number of emergency visits and help in the
prevention of future adverse events. The aim of this review was to evaluate the clinical utility of markers of cardiovascular inflammation in emergency patients with ACS. Based on a critical analysis of a selection of the literature, we concluded that none of the biomarkers of cardiovascular inflammation would at present be useful for stratifying risk in
emergency situations, aiding prognosis, or guiding therapy for patients with ACS.